Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.
Browse Full Report Visit - http://www.acutemarketreports.com/report/world-intravenous-iv-ibuprofen-market
The market for IV ibuprofen for pain management is in its nascent stage. The world IV ibuprofen market was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022, registering a CAGR of 20% during the forecast period. Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015, FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a significant growth during the forecast period. Other factors that affect the market growth significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache, toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs. Factors that would hamper the market growth include side effects associated with IV ibuprofen and lengthy approval process.
The world IV Ibuprofen market is segmented on the basis of indication, age group, and country. By indication, further sub-segments considered in this report include pain/inflammation and fever. The age groups considered are pediatrics and adults. The market is segmented into four countries namely Australia, Canada, South Korea, and the U.S.
Currently, Cumberland Pharmaceuticals Inc., is the only IV ibuprofen manufacturer in the market. The company has collaborated with the local/regional drug manufacturers to target new countries by getting product approvals. The key companies profiled in this report are Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc. (acquired by Teligent, Inc.), CSL Limited, Sandor Medicaids Pvt Ltd., PT. Soho Industri Pharmasi, Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., and Laboratorios Valmorca, C.A.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
KEY BENEFITS FOR STAKEHOLDERS:
- This report provides an extensive analysis of the current and emerging trends and dynamics in the world IV Ibuprofen market.
- The world IV Ibuprofen market is analyzed based on countries such as the U.S., Australia, Canada and South Korea.
- The study evaluating competitive landscape has been taken into account to understand the competitive environment across the countries considered.
- This report provides detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists to identify the prevailing opportunities.
- Exhaustive analysis of the world IV Ibuprofen market by indication describes the types of indications that will gain prominence in future.
INTRAVENOUS (IV) IBUPROFEN MARKET KEY SEGMENTS:
By Indication
- Pain/Inflammatory
- Fever
By Age Group
- Pediatrics
- Adults
By Country
- Australia
- Canada
- South Korea
- U.S.
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Moderate scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Moderate scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.4 Government regulations
3.5 Research & Analysis
3.5.1 Clinical trials
3.6 Market dynamics
3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.4 Government regulations
3.5 Research & Analysis
3.5.1 Clinical trials
3.6 Market dynamics
3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities
Our Blogs :-
http://www.qyresearchreports.net/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/
For Technology News : http://www.mobilecomputingtoday.co.uk/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
No comments:
Post a Comment